SC
RGDX

Sophrosyne Capital’s RESPONSE GENETICS, INC COMMON SHS (DELAWARE) RGDX Stock Holding History

Sophrosyne Capital’s Portfolio RGDX Stock Details RGDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-487,805
Closed -$1.08M – 82
2013
Q3 		$1.08M Buy
+487,805
New +$985K 0.72% 38

Other funds holding RGDX

BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
LPLP
Lansdowne Partners Limited Partnership London, United Kingdom $11.9B AUM 36% 1-Year Est. Return
AWMDMG
Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Sophrosyne Capital's RGDX Position: Q4 2013 in Review

Sophrosyne Capital sold out of RESPONSE GENETICS, INC COMMON SHS (DELAWARE) (RGDX) in Q4 2013, closing a stake of 487,805 shares — an estimated $1.08M sold.

Sophrosyne Capital first reported a position in RGDX in Q3 2013 and held it in 1 quarter. The position peaked at $1.08M in Q3 2013. 18 funds tracked by Wall St. Rank hold RGDX as of Q4 2013.

  • Sophrosyne Capital reported no remaining RESPONSE GENETICS, INC COMMON SHS (DELAWARE) position as of Q4 2013 after selling out during the quarter.
  • Sophrosyne Capital sold 487,805 RESPONSE GENETICS, INC COMMON SHS (DELAWARE) shares in Q4 2013, an estimated $1.08M.
  • Sophrosyne Capital first reported a position in RESPONSE GENETICS, INC COMMON SHS (DELAWARE) in Q3 2013 and held it in 1 quarter.
  • Sophrosyne Capital's RESPONSE GENETICS, INC COMMON SHS (DELAWARE) position peaked at $1.08M in Q3 2013.
  • 18 funds tracked by Wall St. Rank held RESPONSE GENETICS, INC COMMON SHS (DELAWARE) as of Q4 2013.

Based on Sophrosyne Capital's 13F filing for Q4 2013, filed 13 Feb 2014.